Navigation Links
'Nanosensors' Spot Early Signs of Cancer
Date:12/13/2009

Blood-based technology could lead to quicker detection and treatment, study says

SUNDAY, Dec. 13 (HealthDay News) -- Miniature "nanosensors" can detect early signs of cancer in everyday blood samples taken from patients, researchers report.

The sensors hunted for and picked up biomarkers for prostate and breast cancers. Study co-author Mark Reed, associate director of the Yale Institute for Nanoscience and Quantum Engineering in New Haven, Conn., said the technology "can generally be applied to many other types of biomarkers."

The ultimate, hoped-for outcome is quick, easy and low-cost tests that can be done in a doctor's office to detect cancer before it becomes troublesome.

"From a personalized medicine point of view, you could take a spot of blood from a fingerprick and get results within minutes. It would be simple, stable and relatively inexpensive," said William C. Phelps, program director of Translational and Preclinical Cancer Research at the American Cancer Society.

"There's a crying need for things like this in lung cancer, where you would want to be able to detect biomarkers in a sputum sample, and pancreatic and ovarian cancer," Phelps said. "You can't really detect these early, so they're very hard to treat," he noted.

"You want to detect a particular protein in the blood that's indicative of disease and you want to detect it early with high specificity and accuracy. You don't want false-positives or false-negatives," Phelps added.

Although the technology has yet to make it to the doctor's office, it is revolutionary in more than one way.

Previous technologies work in much the same way, but can only detect biomarkers in purified solutions, not the real thing -- meaning fluid samples from patients.

"The real achievement here was demonstrating this with blood, which was a longstanding goal," Reed explained. "It could not be done before because blood has too much salt and other stuff in it, which prevents this type of sensing. We developed a method to filtrate out specifically what we want to detect."

Only small amounts of blood were needed and the process took all of 20 minutes.

The study findings were published online Dec. 13 in the journal Nature Nanotechnology.

Nanotechnology is able to work at the sub-cellular level, said Yoed Rabin, associate professor of biothermal technology at Carnegie Mellon University in Pittsburgh.

These particular nanosensors in the new study, Reed said, "sense the absorption of molecules on its surface and give an electrical signal output."

Much of these innovations are a direct outgrowth of the Human Genome Project, which identified and sequenced the entire human genome of about 30,000 genes, Phelps said.

Although not too many cancer biomarkers have been identified, the Human Genome Project should yield many more.

"This gives a wonderful catalogue and characterization of cells and cancer cells that could be markers, so the biological underpinnings to do this are well in hand," Phelps said. "If you find a protein, you can go back and say this protein is connected to this gene and this gene is more often expressed in cancer."

More information

To learn more, visit the National Nanotechnology Initiative.



SOURCES: Mark Reed, Ph.D., associate director, Yale Institute for Nanoscience and Quantum Engineering, New Haven, Conn.; Yoed Rabin, Ph.D., associate professor, biothermal technology, Carnegie Mellon University, Pittsburgh; William C. Phelps, Ph.D., program director, Translational and Preclinical Cancer Research, American Cancer Society; Dec. 13, 2009, Nature Nanotechnology, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pot bellies linked to early signs of cardiovascular disease
2. Eye-staining technique offers early detection for dry eye syndrome
3. Early Weight Loss in Women Linked to Dementia
4. Isolation of a new gene family essential for early development
5. U of M study: Early treatment can reverse heart damage
6. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
7. Rock N Roll: Sex, Drugs and an Early Exit
8. Pop stars more than twice as likely to die an early death
9. Exercise and yoga improves quality of life in women with early-stage breast cancer
10. Research says doctors gender may hinder early diagnosis of heart disease in women
11. Antidepressant shows early promise in treating agitation and psychotic symptoms of dementia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... -- AVACEN Medical , Inc. (AVACEN) announced that Frost ... Product Innovation Award for Its fibromyalgia pain management device. ... device market research by Frost & Sullivan,s industry experts. ... relief product, the AVACEN 100, offers a safe and effective ... ...
(Date:10/12/2017)... -- West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today announced that it will release third-quarter 2017 ... 26, 2017, and will follow with a conference call ... a.m. Eastern Time. To participate on the call, please ... is 94093362. A ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  Caris Life ... focused on fulfilling the promise of precision medicine, today ... has joined Caris, Precision Oncology Alliance™ (POA) as its ... cancer centers, the St. Jude Crosson Cancer Institute will ... advance the use of tumor profiling, making cancer treatment ...
Breaking Medicine Technology: